Infinity to Present at Upcoming Conferences

  Infinity to Present at Upcoming Conferences

Cowen Group Healthcare Conference 2013 Barclays Global Healthcare Conference

Business Wire

CAMBRIDGE, Mass. -- February 25, 2013

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will present at the following
investor conferences:

  *Cowen and Company 33rd Annual Health Care Conference, Boston, March 4,
    2013, at 4:50 p.m. ET
  *Barclays Global Healthcare Conference, Miami, March 12, 2013, at 9:30 a.m.
    ET
  *Bernstein Emerging Biotech Conference 2013, Snowbird, UT, March 12, 2013,
    at 4:00 p.m. MT (2:00 p.m. ET) (no webcast available)

The presentations at the Cowen and Company and Barclays conferences will be
webcast. Live audio webcasts and replays of these presentations will be
accessible on the “investors/media” section of the company's website,
www.infi.com, and will be available for 30 days following each event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.

Contact:

Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com
 
Press spacebar to pause and continue. Press esc to stop.